ArticleJournal of diabetes and metabolic disorders2025
Adherence to Portfolio diet and risk of type 2 diabetes mellitus in a population-based prospective cohort study.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Plant-Based Diets and Cardiometabolic Diseases in a Cohort of Iranian Adults: A Systematic Review of Evidence from the Tehran Lipid and Glucose Study.International journal of endocrinology and metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes mellitus (T2DM) poses significant global health challenges, with its rising prevalence linked closely to lifestyle and dietary factors. The Portfolio Diet, a plant-based dietary regimen known to lower cholesterol and cardiovascular disease, may also offer protective effects against T2DM, though limited research has explored this potential association. This study investigates the relationship between adherence to the Portfolio Diet and T2DM risk within the Tehran Lipid and Glucose Study (TLGS) during 8.9 years of follow-up, a population-based prospective study. Methods: This analysis included 2,188 T2DM-free adults, aged ≥ 21. Dietary intake was assessed using a validated and reliable FFQ, and adherence to the Portfolio Diet was evaluated through a Portfolio Diet Score (PDS) derived from the dietary intake data. Cox proportional hazard models, adjusted for demographic and lifestyle factors, were employed to assess the association between PDS and T2DM risk. Results: Overall PDS were not statistically significantly associated with T2DM risk across the tertiles in fully adjusted models (HR = 0.91; 95%CI: 0.64-1.31, P trend = 0.610). Analysis of individual PDS components indicated an inverse association between nuts intake and T2DM risk in the highest tertile (HR = 0.72, 95% CI: 0.51-0.99; P trend = 0.050). Other components, including plant protein, viscose fiber, monounsaturated fatty acids (MUFA), and total phytosterols, did not show significant associations with T2DM risk in adjusted models. Conclusions: While overall adherence to the portfolio diet did not significantly reduce T2DM risk in this Middle Eastern cohort, nut consumption was inversely associated with T2DM incidence. These findings indicate that both region-specific dietary patterns and the weighting of components within the Portfolio Diet Score may affect its ability to capture associations with type 2 diabetes risk. Clinical trial number: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.